Global Viral Inactivation Market to Reach Global Viral Inactivation Market to Reach USD 2273.73 Million by 2035, Aided by the Rising Prevalence of Chronic Diseases by 2035, Aided by the Rising Prevalence of Chronic Diseases

The increasing number of new drug launches is a key factor driving the market growth. The increased risk of cell culture contamination, rising healthcare expenditures, advancements in nanofiltration technology, and the rising incidence of chronic diseases globally are the major factors driving the viral inactivation market. In the forecasted period, rising pharmaceutical outsourcing and growth in emerging markets would generate new prospects for the viral inactivation industry. The viral inactivation industry is also driven by stringent regulations controlling the pharmaceutical and related sectors in a number of developed economies, which govern the safety of drug development procedures and the efficiency of quality control and quality assurance criteria. In the coming years, incidents related to the recall of flawed vaccinations that may have a severe health impact on users in a number of countries are projected to raise demand for effective viral inactivation techniques in vaccines. One of the major factors encouraging the need for viral inactivation around the world is growing concerns about the transmission of blood-borne viruses through plasma-derived medical products.

The majority of the players are focusing on the development of new products. In September 2019, Merck KGaA announced the purchase of Pfizer Inc. and the introduction of BAVENCIO, a new medication that aims to cure a variety of illnesses, including cancers such as renal cell carcinoma and metastatic cancer, among others.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis by Product, Application, End Use, and Regions:

• Based on product, the market is categorised into kits and reagents, systems, and services.
• The significant applications of the market are vaccines and therapeutics, stem cell products, blood and blood products, tissue and tissue products, and cellular and gene therapy.
• The various end uses in the market are pharmaceutical and biotechnology companies, CROs, academic and research institutes, among others.
• The regional markets for viral inactivation include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• As a result of technology advancements and the patent expiration of prominently branded pharmaceuticals, the market is likely to be in high demand.
• Increased research and development innovation in many applications, such as stem cell research and cellular and gene therapy, has also contributed significantly to market expansion.
• The rapidly ageing population and increased obesity rates in various regions is expected to augment the growth of the market.
• The growing public and private initiatives to increase awareness related to health and safety of the medicinal treatment and an increasing number of private sector hospitals is driving the growth of the market.

Key Offerings of the Report:

• The EMR report gives an overview of the global viral inactivation market for the periods (2019-2025) and (2026-2035).
• The report also offers the historical (2019-2025) and forecasted (2026-2035) markets for product, application, end use, and major regions of viral inactivation.
• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

Top Players

• Rad Source Technologies Inc
• Merck KGaA
• Parker Hannifin Corp
• Sartorius AG
• Cerus Corporation
• Cytiva (Danaher Corporation)
• Charles River Laboratories
• CONVATEC GROUP PLC
• WuXi AppTec
• TERUMO BCT, INC.
• Thermo Fisher Scientific Inc.
• SCI Automation

The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium-sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790